Clinical Trials Browser

Phase 4 × Neoplasm Metastasis × 30 days × Clear all

NCT07446465 2026-03-03

FOLFOX Chemotherapy Combined With Fruquintinib and Serplulimab as First-Line Conversion Therapy for Initially Unresectable pMMR/MSS Colorectal Cancer

Phase 4 Not yet recruiting

Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms